Thompson P - Search Results

1

Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.

Hill A, Bergin P, Hanning F, Thompson P, Findlay M, Damianovich D, McKeage MJ. Hill A, et al. Among authors: thompson p. BMC Cancer. 2010 Aug 23;10:451. doi: 10.1186/1471-2407-10-451. BMC Cancer. 2010. PMID: 20731872 Free PMC article.

2

Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.

Jackson CG, Sharples K, Thompson PI, O'Donnell A, Robinson BA, Perez DJ, Adams J, Isaacs R, Deva S, Hinder VA, Findlay MP. Jackson CG, et al. Among authors: thompson pi. BMC Cancer. 2014 Oct 2;14:737. doi: 10.1186/1471-2407-14-737. BMC Cancer. 2014. PMID: 25274181 Free PMC article. Clinical Trial.

3

Evidence-based update of chemotherapy options for metastatic colorectal cancer.

Damjanovic D, Thompson P, Findlay MP. Damjanovic D, et al. Among authors: thompson p. ANZ J Surg. 2004 Sep;74(9):781-7. doi: 10.1111/j.1445-1433.2004.03148.x. ANZ J Surg. 2004. PMID: 15379811 Review.

4

Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?

Lawrence N, Hinder V, Murray M, Macapagal J, Thompson P, Sharples K, Findlay M. Lawrence N, et al. Among authors: thompson p. Asia Pac J Clin Oncol. 2017 Apr;13(2):e124-e131. doi: 10.1111/ajco.12402. Epub 2015 Aug 6. Asia Pac J Clin Oncol. 2017. PMID: 26245738

5

Transient retinal effects of 5,6-dimethylxanthenone-4-acetic acid (DMXAA, ASA404), an antitumor vascular-disrupting agent in phase I clinical trials.

Jameson MB, Sharp DM, Sissingh JI, Hogg CR, Thompson PI, McKeage MJ, Jeffery M, Waller S, Acton G, Green C, Baguley BC. Jameson MB, et al. Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2553-9. doi: 10.1167/iovs.08-2068. Epub 2009 Apr 22. Invest Ophthalmol Vis Sci. 2009. PMID: 19387077 Clinical Trial.

6

Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma.

Samuel LM, Harvey VJ, Mitchell PL, Thompson PI, Mak D, Melville P, Evans BD. Samuel LM, et al. Among authors: thompson pi. Eur J Cancer. 1994;30A(14):2054-6. doi: 10.1016/0959-8049(94)00273-8. Eur J Cancer. 1994. PMID: 7857702 Clinical Trial.

7

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent.

Jameson MB, Thompson PI, Baguley BC, Evans BD, Harvey VJ, Porter DJ, McCrystal MR, Small M, Bellenger K, Gumbrell L, Halbert GW, Kestell P; Phase I/II Trials Committee of Cancer Research UK. Jameson MB, et al. Among authors: thompson pi. Br J Cancer. 2003 Jun 16;88(12):1844-50. doi: 10.1038/sj.bjc.6600992. Br J Cancer. 2003. PMID: 12799625 Free PMC article. Clinical Trial.

8

Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centres.

Jameson MB, Evans BD, Gray DH, Forgeson GV, Allan SG, Humm G, Thomson J, Thompson PI, Harvey VJ. Jameson MB, et al. Among authors: thompson pi. Aust N Z J Med. 1995 Jun;25(3):224-9. doi: 10.1111/j.1445-5994.1995.tb01527.x. Aust N Z J Med. 1995. PMID: 7487690

9

Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.

McCrystal MR, Evans BD, Harvey VJ, Thompson PI, Porter DJ, Baguley BC. McCrystal MR, et al. Among authors: thompson pi. Cancer Chemother Pharmacol. 1999;44(1):39-44. doi: 10.1007/s002800050942. Cancer Chemother Pharmacol. 1999. PMID: 10367747 Clinical Trial.

10

Curable chemotherapy.

Thompson PI, Harvey VJ. Thompson PI, et al. N Z Med J. 1987 Oct 28;100(834):653-5. N Z Med J. 1987. PMID: 3452130 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,482 results

Search Page